Norman Swan : Remember, these are originally designed for people with type two diabetes, also in people with obesity, and particularly obesity and chronic diseases like heart disease and kidney damage, and they're very effective for that
MEN2 is considered an autosomal dominant familial disorder
GLP-1 receptor agonists work by reducing systemic inflammation and oxidative stress, which are two primary drivers of renal scarring
CJC-1295 (No DAC) + Ipamorelin 10mg
This fundamental difference means their effects on glucose metabolism can work against each other, potentially requiring dose adjustments to either medication
Klinic has carefully curated alternatives like Wegovy, Oral Wegovy, Zepbound, and Foundayo, each clinically approved for managing weight